In vivo percutaneous penetration/absorption : Sponsored by the American Association of Pharmaceutical Scientist, U.S. Food and Drug Administration, American Academy of Dermatology, Skin Pharmacology Society and the U.S. Army Environmental Hygiene Agency May 1-3, 1989, Washington, DC
dc.contributor.author | Snah, Vinod P. | en_US |
dc.contributor.author | Flynn, Gordon L. | en_US |
dc.contributor.author | Guy, Richard H. | en_US |
dc.contributor.author | Maibach, Howard I. | en_US |
dc.contributor.author | Schaefer, Hans | en_US |
dc.contributor.author | Skelly, Jerome P. | en_US |
dc.contributor.author | Wester, Ronald C. | en_US |
dc.contributor.author | Yacobi, Avraham | en_US |
dc.contributor.author | Anderson, Bradley D. | en_US |
dc.contributor.author | Andersen, Klaus E. | en_US |
dc.date.accessioned | 2006-04-10T14:37:13Z | |
dc.date.available | 2006-04-10T14:37:13Z | |
dc.date.issued | 1991-08-02 | en_US |
dc.identifier.citation | Snah, Vinod P., Flynn, Gordon L., Guy, Richard H., Maibach, Howard I., Schaefer, Hans, Skelly, Jerome P., Wester, Ronald C., Yacobi, Avraham, Anderson, Bradley D., Andersen, Klaus E. (1991/08/02)."In vivo percutaneous penetration/absorption : Sponsored by the American Association of Pharmaceutical Scientist, U.S. Food and Drug Administration, American Academy of Dermatology, Skin Pharmacology Society and the U.S. Army Environmental Hygiene Agency May 1-3, 1989, Washington, DC." International Journal of Pharmaceutics 74(1): 1-8. <http://hdl.handle.net/2027.42/29180> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T7W-4772DCV-1J/2/9cd44906526c5eb0dd202b7f06263488 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/29180 | |
dc.description.abstract | This workshop, `In Vivo Percutaneous Penetration/Absorption' was held in Washington, DC, on May 1-3, 1989. The first workshop in this series, `In Vitro Percutaneous Penetration', took place in November 1986 (the report of this earlier meeting was published in Pharmaceutical Research, 4 (1987) 265-267). The objectives of the workshop were to review the relevant literature and to address in detail: (1) In vivo percutaneous penetration/absorption methodology; (2) The characteristics of dosage forms designed for application to the skin; (3) Critical factors controlling in vivo drug transport into and across the skin; (4) The use of models in the assessment and evaluation of in vivo percutaneous penetration/absorption; and (5) Bioavailability/bioequivalence considerations for topical drug products. Scientific knowledge and technology are rapidly evolving in the topical and transdermal drug products area. This report focuses on the methodologies available for the measurement of percutaneous penetration in vivo; each scientific approach is discussed briefly followed by advantages and disadvantages of the methodology. | en_US |
dc.format.extent | 588941 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | In vivo percutaneous penetration/absorption : Sponsored by the American Association of Pharmaceutical Scientist, U.S. Food and Drug Administration, American Academy of Dermatology, Skin Pharmacology Society and the U.S. Army Environmental Hygiene Agency May 1-3, 1989, Washington, DC | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, College of Pharmacy, Ann Arbor, MI 48109, U.S.A. | en_US |
dc.contributor.affiliationother | Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, U.S.A. | en_US |
dc.contributor.affiliationother | University of California, School of Pharmacy, San Francisco, CA 94143, U.S.A. | en_US |
dc.contributor.affiliationother | University of California, Department of Dermatology, San Francisco, CA 94143, U.S.A. | en_US |
dc.contributor.affiliationother | Centre International de Recherches Dermatologiques, Sophia Antipolis, 06565, Valbonne Cedex, France | en_US |
dc.contributor.affiliationother | Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, U.S.A. | en_US |
dc.contributor.affiliationother | University of California, School of Pharmacy, San Francisco, CA 94143, U.S.A. | en_US |
dc.contributor.affiliationother | American Cyanamid Company, Pearl River, NY 10965, U.S.A. | en_US |
dc.contributor.affiliationother | University of Utah, Department of Medicine, Division of Dermatology, Salt Lake City, UT 84132, U.S.A. | en_US |
dc.contributor.affiliationother | Department of Dermatology, Odense University Hospital, Odense, Denmark | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/29180/1/0000227.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0378-5173(91)90402-A | en_US |
dc.identifier.source | International Journal of Pharmaceutics | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.